Company Filing History:
2 out of 4 
1 out of 2 Years Active: 2020-2021
Title: Da-Wei Sun: Innovator in Recombinant Polypeptides
Introduction
Da-Wei Sun is a prominent inventor based in Taipei, Taiwan. He has made significant contributions to the field of biotechnology, particularly in the development of recombinant polypeptides. With a total of two patents to his name, his work has implications for various applications in medicine and research.
Latest Patents
Da-Wei Sun's latest patents focus on recombinant polypeptides, compositions, and methods thereof. The first patent provides recombinant polypeptides, homodimeric and heterodimeric proteins comprising these polypeptides, as well as nucleic acid molecules encoding them. It also includes vectors and host cells that incorporate these nucleic acid molecules. The second patent similarly details recombinant polypeptides and nucleic acid molecules, along with their compositions and methods of making and using them.
Career Highlights
Throughout his career, Da-Wei Sun has worked with notable companies such as Biogend Therapeutics Co., Ltd. and Osteopharma Inc. His experience in these organizations has allowed him to advance his research and contribute to innovative solutions in biotechnology.
Collaborations
Da-Wei Sun has collaborated with esteemed colleagues, including Pei-Wen Hsu and Chien-Pei Chen. These partnerships have fostered a collaborative environment that enhances the development of new technologies and methodologies.
Conclusion
Da-Wei Sun is a distinguished inventor whose work in recombinant polypeptides has the potential to impact various fields significantly. His patents and collaborations reflect his commitment to advancing biotechnology and improving health outcomes.